Search - tctmd.com

Displaying 1 - 20 of 217

Sort: Relevancy | Date

News Conference News TCT 2025

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Yael L. Maxwell

November 07, 2025

News Conference News TCT 2025

SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI

Caitlin E. Cox

November 06, 2025

News Conference News TCT 2025

Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE

Caitlin E. Cox

October 28, 2025

News Conference News TCT 2025

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

Todd Neale

October 28, 2025

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

News Conference News AHA 2024

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Shelley Wood

November 17, 2024

Presentation TCT 2024

Quantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization

Presenter: Birgitte Krogsgaard Andersen

October 30, 2024

Presentation TCT 2024

Case Based Example 2

Presenter: Margaret McEntegart

October 30, 2024

Presentation TCT 2024

A Primer on DCB Technology and Requirements for Success

Presenter: Juan Granada

October 30, 2024

Presentation TCT 2024

Case Based Example 1

Presenter: Bernardo Cortese

October 30, 2024

Presentation TCT 2024

Top Five Insights from the ARC-DCB Consortium

Presenter: Simone Fezzi

October 30, 2024

Presentation TCT 2024

How I Use DCBs: A Lens Into the Future

Presenter: Antonio Colombo

October 30, 2024

Presentation TCT 2024

What are the Evidence Gaps for DCBs?

Presenter: Joanna Wykrzykowska

October 30, 2024

Presentation TCT 2024

Myocardial Bridges: Cross With Caution

Presenter: Sanjog Kalra

October 30, 2024

Presentation TCT 2024

Coronary Microvascular Disease -- How Do We Move the Field Forward?

Presenter: Rasha Al-Lamee

October 30, 2024

Presentation TCT 2024

INOCA, ANOCA, MINOCA: Making Sense of Alphabet Soup

Presenter: Jennifer Tremmel

October 30, 2024

Presentation TCT 2024

Spontaneous Coronary Artery Dissection: Future Directions

Presenter: Christina Magnussen

October 30, 2024

Presentation TCT 2024

Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis: The CLEAR IE Multicenter Registry

Presenter: Abdallah El Sabbagh

October 30, 2024

Presentation TCT 2024

The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System

Presenter: Olivier Bertrand

October 30, 2024

Presentation TCT 2024

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Presenter: Hongbo Yang

October 30, 2024

Advertisement

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI

Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY

Quantitative Flow Ratio or Fractional Flow Reserve for Guiding Coronary Revascularization

Case Based Example 2

A Primer on DCB Technology and Requirements for Success

Case Based Example 1

Top Five Insights from the ARC-DCB Consortium

How I Use DCBs: A Lens Into the Future

What are the Evidence Gaps for DCBs?

Myocardial Bridges: Cross With Caution

Coronary Microvascular Disease -- How Do We Move the Field Forward?

INOCA, ANOCA, MINOCA: Making Sense of Alphabet Soup

Spontaneous Coronary Artery Dissection: Future Directions

Outcomes of Percutaneous Mechanical Aspiration in Right-Sided Infective Endocarditis: The CLEAR IE Multicenter Registry

The TARGET-IV Trial: International Multicenter Randomized Assessment of the Firehawk® Rapamycin Eluting Coronary Stent System

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content